For patients with type 2 diabetes (T2D) and chronic obstructive pulmonary disorder (COPD), sodium-glucose cotransporter-2 inhibitors (SGLT-2is) and glucagon-like peptide-1 receptor agonists (GLP-1 RAs ...

People with type 2 diabetes who take GLP-1 and SGLT-2 medications have a lower risk of having COPD symptom flare-ups than ...

Individuals with asthma and chronic obstructive pulmonary disease (COPD) were more vulnerable than healthy controls to ...

Research reveals GLP-1 and SGLT-2 medications may lower COPD exacerbation risk in diabetes, offering new hope for dual ...

A multimodal, digital community-based intervention was feasible and decreased illness-related distress in treating patients ...

In COPD, muscular atrophy is a significant risk factor for death and may prolong patients’ hospital length of stay.

chronic obstructive pulmonary disease (COPD), and ... How a New Gut Microbe Drives the Gut-Lung Axis Dec. 19, 2024 — A team has discovered a new communication pathway between the gut and lung.

As Pope Francis battles dangerous lung infection, here’s what you need to know about the causes, symptoms, prevention tips and treatment of double pneumonia.

A new laser-based device can scan almost any sample of gas and detect its molecular ingredients down to concentrations in the parts per trillion.

Objective: To investigate the efficacy and tolerability of high-dose N-acetylcysteine (NAC) in the treatment of patients with exacerbations of chronic obstructive pulmonary disease (COPD).